Top

World Journal of Surgical Oncology

Published in:

Open Access 01-12-2014 | Research

Treatment and prognosis of type B2 thymoma

Authors: Zhengbo Song, Xiangyu Jin, Yiping Zhang

Published in: World Journal of Surgical Oncology | Issue 1/2014

Abstract

Background

Because of the rarity of thymoma, no randomized trials have prospectively detected the prognosis and optimal treatment for type B2 thymoma. The aim of this study is to investigate the treatment and prognosis for patients with type B2 thymoma.

Methods

We retrospectively evaluated the outcome of 42 patients with type B2 thymoma who were treated between 1995 and 2010 in Zhejiang Cancer Hospital. Survival curves were plotted using the Kaplan–Meier method. The Cox proportional hazard model was used for multivariate analysis.

Results

The current study included 42 patients. The 5-year disease-free survival and overall survival rates were 62.8% and 84.9%, respectively. There were significant differences in disease-free survival and overall survival among different Masaoka stages (both P < 0.001). Univariate and multivariate analysis revealed that Masaoka stage was associated with disease-free survival and overall survival (P = 0.00 and 0.001, respectively).

Conclusions

Our results indicate that Masaoka stage affects disease-free survival and overall survival of patients with type B2 thymoma.

Available only for authorised users

De Jong WK, Blaauwgeers JL, Schaapveld M, Timens W, Klinkenberg TJ, Groen HJ: Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer. 2008, 44: 123-130. 10.1016/j.ejca.2007.11.004.CrossRefPubMed

Dadmanesh F, Sekihara T, Rosai J: Histologic typing of thymoma according to the new World Health Organization classification. Chest Surg Clin N Am. 2001, 11: 407-420.PubMed

Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, Maeda H, Tada H, Eimoto T, Matsuda H, Masaoka A: The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer. 2002, 94: 624-632. 10.1002/cncr.10226.CrossRefPubMed

Shen S, Ai X, Lu S: Long-term survival in thymic epithelial tumors: a single-center experience from China. J Surg Oncol. 2013, 107: 167-172. 10.1002/jso.23256.CrossRefPubMed

Marchevsky AM, Gupta R, Casadio C, Hiroshima K, Jambhekar NA, Kim DJ, Nakatani Y, Okumura M, Rena O, Yoshida S: World Health Organization classification of thymomas provides significant prognostic information for selected stage III patients: evidence from an international thymoma study group. Hum Pathol. 2010, 41: 1413-1421. 10.1016/j.humpath.2010.02.012.CrossRefPubMed

Kim DJ, Yang WI, Choi SS, Kim KD, Chung KY: Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors: a clinicopathologic study of 108 patients and literature review. Chest. 2005, 127: 755-761. 10.1378/chest.127.3.755.CrossRefPubMed

Chen G, Marx A, Chen WH, Yong J, Puppe B, Stroebel P, Mueller-Hermelink HK: New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer. 2002, 95: 420-429. 10.1002/cncr.10665.CrossRefPubMed

Rieker RJ, Hoegel J, Morresi-Hauf A, Hofmann WJ, Blaeker H, Penzel R, Otto HF: Histologic classification of thymic epithelial tumors: comparison of established classification schemes. Int J Cancer. 2002, 98: 900-906. 10.1002/ijc.10255.CrossRefPubMed

Gao L, Wang C, Fang W, Zhang J, Lv C, Fu S: Outcome of multimodality treatment for 188 cases of type B3 thymoma. J Thorac Oncol. 2013, 8: 1329-1334. 10.1097/JTO.0b013e31829ceb50.CrossRefPubMed

10.

Demirci S, Turhan K, Ozsan N, Yalman D, Cakan A, Cok G, Cagirici U, Ozkok S: Prognostic factors for survival in patients with thymic epithelial tumors. Thorac Cardiovasc Surg. 2011, 59: 153-157. 10.1055/s-0030-1250657.CrossRefPubMed

11.

Asamura H, Nakagawa K, Matsuno Y, Suzuki K, Watanabe S, Tsuchiya R: Thymoma needs a new staging system. Interact Cardiovasc Thorac Surg. 2004, 3: 163-167. 10.1016/S1569-9293(03)00265-2.CrossRefPubMed

12.

Kondo K, Monden Y: Thymoma and myasthenia gravis: a clinical study of 1,089 patients from Japan. Ann Thorac Surg. 2005, 79: 219-224. 10.1016/j.athoracsur.2004.06.090.CrossRefPubMed

13.

Okereke IC, Kesler KA, Morad MH, Mi D, Rieger KM, Birdas TJ, Badve S, Henley JD, Turrentine MW, Nelson RP, Loehrer PJ: Prognostic indicators after surgery for thymoma. Ann Thorac Surg. 2010, 89: 1071-1079. 10.1016/j.athoracsur.2010.01.026.CrossRefPubMed

Title: Treatment and prognosis of type B2 thymoma
Authors: Zhengbo Song
Xiangyu Jin
Yiping Zhang
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: World Journal of Surgical Oncology / Issue 1/2014
Electronic ISSN: 1477-7819
DOI: https://doi.org/10.1186/1477-7819-12-291

At a glance: The STEP trials

Springer Medicine

Treatment and prognosis of type B2 thymoma

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2014

Surgery and outcomes of six patients with intradural epidermoid cysts in the lumbar spine

Prognostic value of poorly differentiated clusters in invasive breast cancer

Robotic pancreaticoduodenectomy in a case of duodenal gastrointestinal stromal tumor

Rectal cancer surgery in older people does not increase postoperative complications - a retrospective analysis

Gastroenteropancreatic neuroendocrine tumour arising in Meckel’s diverticulum coexisting with colon adenocarcinoma

Percutaneous transhepatic placement of a stent-graft to treat a delayed mesoportal hemorrhage after pancreaticoduodenectomy